[{"Assets_0_Q1_USD":"15757500000.0","CIK":"872589","Country":"United States","EarningsPerShareBasic_1_Q1_USD":"5.69","EarningsPerShareDiluted_1_Q1_USD":"5.43","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"77738004554.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":"698000000.0","NetIncomeLoss_1_Q1_USD":"624600000.0","OfficialName":"Regeneron Pharmaceuticals Inc. Common Stock","RevenuesConverted_1_Q1_USD":"1828200000.0","SP500":"SP500","Sector":"Health Care","StockholdersEquity_0_Q1_USD":"12133000000.0","Ticker":"REGN","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":"115100000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":"109800000.0","filed":"20200505","footnote":null,"form":"10-Q","fp":"Q1","fy":"2020.0","name":"REGENERON PHARMACEUTICALS, INC.","period":"20200331","qtrs":"0","uom":"USD"}]